Código 293420 (Harmonized System 2012 by 6 digits)
2023: US$25.3M, Total Trade Exchange
2023: US$206k, International Sales
2023: US$25.1M, International Purchases
In 2023, the trade exchange (includes international purchases and sales) of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused was US$25.3M.
In 2023, the states with the most international sales in Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused were Guanajuato (US$43.1k), Ciudad de México (US$35.5k), and Estado de México (US$27.8k).
The states with the most international purchases in 2023 were Querétaro (US$8.49M), Ciudad de México (US$8.24M), Guanajuato (US$4M), San Luis Potosí (US$2.31M), and Jalisco (US$836k).
In 2023, the main commercial destinations of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused were Guatemala (US$39.3k), Dominican Republic (US$29.6k), Costa Rica (US$23.8k), United States (US$10.7k), and Italy (US$2.83k).
The main commercial origins of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused in 2023 were China (US$21.5M), Belgium (US$1.91M), United States (US$900k), India (US$623k), and Hong Kong (US$66.8k).
In the global context, the main exporting countries of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused in 2022 were China (US$496M), Belgium (US$105M), and Spain (US$52.5M). In the same year, the main importing countries of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused were United States (US$143M), Germany (US$79.2M), and Japan (US$68.3M).
US$25.3M, Total Trade Exchange (2023)
In 2023, the total trade exchange of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused in Mexico (including international purchases and sales) was US$25.3M.
The visualizations show the net balance of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
July, 2024
In July 2024, international sales of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused were US$5.35k, while international purchases reached US$2.32M. The above results in a trade balance of -US$2.32M.
Guanajuato: US$43.1k, State with the Most International Sales (2023)
Guatemala: US$39.3k, Main commercial destination (2023)
In 2023, the states with the highest international sales in Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused were Guanajuato (US$43.1k), Ciudad de México (US$35.5k), and Estado de México (US$27.8k).
In 2023, the countries with the most international purchases from Mexico were Guatemala (US$39.3k), Dominican Republic (US$29.6k), Costa Rica (US$23.8k), United States (US$10.7k), and Italy (US$2.83k).
Querétaro: US$8.49M, State with the Most International Purchases (2023)
China: US$21.5M, Main Commercial Origin (2023)
In 2023, the states with the highest international in Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused were Querétaro (US$8.49M), Ciudad de México (US$8.24M), Guanajuato (US$4M), San Luis Potosí (US$2.31M), and Jalisco (US$836k).
The countries with the most international sales to Mexico in 2023 were China (US$21.5M), Belgium (US$1.91M), United States (US$900k), India (US$623k), and Hong Kong (US$66.8k).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused were China (US$496M), Belgium (US$105M), and Spain (US$52.5M). In the same year, the main importing countries for Heterocyclic Compounds Containing in the Structure Benzothiazole, Incl. Hydrogenated, not further Fused were United States (US$143M), Germany (US$79.2M), and Japan (US$68.3M).